Sick of high drug prices, insurers join hospitals to make their own generic medications

23 January 2020 - Everyone complains about high drug prices. But hospitals — and now insurers — are trying to ...

Read more →

FDA grants fast track designation to Arena Pharmaceuticals' APD418 for development in decompensated heart failure patients

16 January 2020 - Arena Pharmaceuticals today announced that the U.S. FDA granted fast track designation for APD418, a β3-adrenergic ...

Read more →

Why Canada won't end up as the drugstore to the U.S.

16 January 2020 - Although in theory the new U.S. import proposals could significantly affect Canadians and their drug supplies, their ...

Read more →

Asfotase alfa in hypophosphatasia in children and adolescents: survival advantage for small children

15 January 2020 - Weak evidence does not allow a specific statement to be made about the extent of the added ...

Read more →

Withdrawal from the drug benefits on 1 February 2020

16 January 2020 - Iressa, Procoralan, Skinoren Cream, Vesicare and Reyataz are among the medicines that are withdrawn from the drug ...

Read more →

EQRX wants to make high-end medicines less costly

17 January 2020 - A Boston-based biotech startup thinks it has found a lucrative third way between high-margin branded drugs and ...

Read more →

Pharma execs pitch ideas at JPM20 to lower drug costs. None of them include dropping their own prices.

16 January 2020 - CEOs from the world’s largest pharmaceutical companies pitched ideas for lowering drug prices at the J.P. Morgan ...

Read more →

TG Therapeutics initiates rolling submission of new drug application to U.S. FDA for umbralisib as a treatment for patients with previously treated marginal zone lymphoma or follicular lymphoma

16 January 2020 - Completion of rolling submission for the MZL/FL NDA expected in 1H20. ...

Read more →

Epilepsy deaths: level of risk in medication brand switch unclear, study says

17 January 2020 - Five deaths in people with epilepsy following a brand switch may be part of an under-represented level ...

Read more →

Nektar issues statement regarding FDA Advisory Committee vote for oxycodegol

15 January 2020 - Nektar Therapeutics issued a statement today following a meeting of the FDA's Anesthetic and Analgesic Drug ...

Read more →

NICE ‘OK’ for Lynparza

16 January 2020 - NICE has recommended MSD and AstraZeneca’s Lynparza (olaparib) tablets, for adults who have relapsed platinum-sensitive ovarian, ...

Read more →

Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund

15 January 2020 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...

Read more →

U.S. targets drug pricing, no-poach deals for anti-trust action in 2020

15 January 2020 - Justice Department antitrust chief also promises decision on music licensing, criticizes states’ lawsuit against T-Mobile and Sprint. ...

Read more →

Prices of MS medications keep soaring

15 January 2020 - The cost of essential medications for multiple sclerosis have nearly tripled this decade, despite the release ...

Read more →

Larotrectinib in tumours with NTRK gene fusion: data are not yet sufficient for derivation of an added benefit

15 January 2020 - First assessment of a histology-independent drug/studies without control arms. ...

Read more →

Novavax granted fast track designation for NanoFlu in older adults

15 January 2020 - Novavax today announced that the U.S. FDA has granted fast track designation for NanoFlu, its recombinant quadrivalent ...

Read more →